Showing results (141-150 of 158) with videos related to
Sort By:
Pageof 16
Epilepsia|October 25, 2025
Chemogenetic astrocyte modulation reduces spontaneous hippocampal discharges and metabolite changes in an epilepsy mouse modelLiam Nestor, Yana Van Den Herrewegen, Marcus Dyer, et al.Disease Models & Mechanisms|September 8, 2022
Targeting firing rate neuronal homeostasis can prevent seizuresFred Mulroe, Wei-Hsiang Lin, Connie Mackenzie-Gray Scott, et al.International Journal of Molecular Sciences|August 26, 2022
Ex Vivo Feedback Control of Neurotransmission Using a Photocaged Adenosine A1 Receptor AgonistErine Craey, Fabian Hulpia, Jeroen Spanoghe, et al.Neuropharmacology|August 14, 2018
Chloride ions stabilize the glutamate-induced active state of the metabotropic glutamate receptor 3Amélie S Tora, Xavier Rovira, Anne-Marinette Cao, et al.Epilepsy & Behavior : E&B|April 8, 2015
Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafishKarine Leclercq, Tatiana Afrikanova, Melanie Langlois, et al.International Journal of Molecular Sciences|March 10, 2017
Caloric Restriction Protects against Lactacystin-Induced Degeneration of Dopamine Neurons Independent of the Ghrelin ReceptorJessica Coppens, Eduard Bentea, Jacqueline A Bayliss, et al.Epilepsia|June 11, 2019
Anticonvulsant and antiepileptogenic effects of system <math></math> inactivation in chronic epilepsy modelsKarine Leclercq, Joeri Van Liefferinge, Giulia Albertini, et al.Nature Neuroscience|June 25, 2002
Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizuresIlse Smolders, Zuner A Bortolotto, Vernon R J Clarke, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 14, 2025
Photopharmacological activation of adenosine A<sub>1</sub> receptor signaling suppresses seizures in a mouse model for temporal lobe epilepsyJeroen Spanoghe, Evelien Wynendaele, Marijke Vergaelen, et al.ACS Chemical Neuroscience|October 24, 2018
Identification of GSK-3 as a Potential Therapeutic Entry Point for EpilepsyNajat Aourz, Ann-Sophie K Serruys, Joëlle N Chabwine, et al.Pageof 16